Cambridge Investment Research Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20K | Sell |
21,500
-575
| -3% | -$535 | ﹤0.01% | 3579 |
|
2025
Q1 | $10K | Sell |
22,075
-1,538
| -7% | -$697 | ﹤0.01% | 3484 |
|
2024
Q4 | $17K | Buy |
+23,613
| New | +$17K | ﹤0.01% | 3430 |
|
2023
Q4 | – | Sell |
-14,239
| Closed | -$16K | – | 3260 |
|
2023
Q3 | $16K | Buy |
+14,239
| New | +$16K | ﹤0.01% | 3093 |
|
2015
Q2 | – | Sell |
-15,086
| Closed | -$100K | – | 1467 |
|
2015
Q1 | $100K | Hold |
15,086
| – | – | ﹤0.01% | 1339 |
|
2014
Q4 | $96K | Buy |
+15,086
| New | +$96K | ﹤0.01% | 1297 |
|